(±)-<em>threo</em>-Ethylphenidate (hydro<wbr>chloride)

(±)-threo-Ethylphenidate (hydrochloride)

CAT N°: 13896

Methylphenidate (a.k.a., Ritalin) is a schedule II drug in the United States commonly used as a psychostimulant for the treatment of attention-deficit hyperactivity disorder (ADHD). Upon ingestion, methylphenidate is predominantly stereoselectively deesterified to the inactive metabolite ritalinic acid.{22009} (±)-threo-Ethylphenidate (hydrochloride) (Item No. 13896) is an analytical reference standard categorized as a phenethylamine. This product is intended for research and forensic applications.

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • (?R,2R)-rel-?-phenyl-2-piperidineacetic acid, ethyl ester, monohydrochloride
  • Correlated keywords
    • 57413-43-1 methylphenidate ritalin attention-deficit attention deficit hyperactivity disorders ADHD ritalinic acids metabolites ethyl esters ethanol dopamine transporters psychostimulant dopamine binds binding activity uptake inhibitions inhibits inhibitors pharmacokinetic analytical references standards 99088-55-8 19716-79-1
  • Product Overview:
    Methylphenidate (a.k.a., Ritalin) is a schedule II drug in the United States commonly used as a psychostimulant for the treatment of attention-deficit hyperactivity disorder (ADHD). Upon ingestion, methylphenidate is predominantly stereoselectively deesterified to the inactive metabolite ritalinic acid.{22009} (±)-threo-Ethylphenidate (hydrochloride) (Item No. 13896) is an analytical reference standard categorized as a phenethylamine. This product is intended for research and forensic applications.

We also advise you